Dialysis PatientsNCT07326306
Dialysis Patients' Perspectives: A Study of the Q Methodology
An observational study of Dialysis Patients, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).
Trial summary
This study was conducted to systematically examine the subjective experiences and perspectives of dialysis patients regarding their treatment modalities. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Dialysis Patients
- How many people
- 26 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Dec 2025to 31 Jan 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The hospital where the study will be conducted has a total of 13 adult peritoneal dialysis patients and 70 adult hemodialysis patients who regularly receive dialysis treatment and attend follow-up appointments. The aim is to study the entire peritoneal dialysis patient population. For hemodialysis patients, a similar number of patients (n=13) to the peritoneal dialysis patients will be selected using a simple randomization method, and these patients will be included in the study.
Who may be able to join
- Being between 18-65 years of age,
- Being able to read and write,
- Not having vision or hearing problems,
- Voluntary participation in our study,
- Being conscious,
- Being a patient with end-stage renal failure,
- Not having communication problems
Who cannot join
- Wishing to withdraw from the research.
Trial locations and contacts
1 site in 1 country.
About this study
This study was conducted to systematically examine the subjective experiences and perspectives of dialysis patients regarding their treatment modalities.
Read the detailed description
In this study, Q methodology was used to systematically examine dialysis patients' subjective experiences and perspectives regarding treatment modalities. Q methodology is a research method that combines qualitative and quantitative paradigms, requiring participants to rank statements expressing their thoughts on a specific topic according to their own perspectives.
- Conditions
- Dialysis Patients
- Keywords
- Q methodology, Peritoneal dialysis, Hemodialysis
What is being measured
The primary outcome is the main question the study is designed to answer.
Perception of dialysis treatment
Hemodialysis patients were asked to rank 24 Q items, developed based on literature review and clinical experience, on a scale from -3 (strongly disagree) to +3 (strongly agree) according to a normal distribution model.
Measured: up to 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2026
- Study start30 Dec 2025
- Primary completion31 Jan 2026
- Study completion31 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dialysis PatientsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yuzuncu Yil University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yavuz Uren, Yuzuncu Yil University
- Investigators
- Yavuz Uren, PhD, Principal investigator, Yuzuncu Yil University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07326306
- Sponsor's protocol ID
- PD-HD Q2
- Status last verified
- Jun 2026
- First submitted
- 22 Dec 2025
- Last updated
- 30 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dialysis Patients' Perspectives: A Study of the Q Methodology
- ClinicalTrials.gov ID
- NCT07326306
- Acronym / sponsor ID
- PD-HD Q2
- Conditions
- Dialysis Patients
- Keywords
- Q methodology, Peritoneal dialysis, Hemodialysis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Yuzuncu Yil UniversityUniversity, hospital or other
- Study start
- 30 Dec 2025 (actual)
- Primary completion
- 31 Jan 2026 (actual)
- Study completion
- 31 Jan 2026 (actual)
- First posted
- 8 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was conducted to systematically examine the subjective experiences and perspectives of dialysis patients regarding their treatment modalities.
Detailed description
In this study, Q methodology was used to systematically examine dialysis patients' subjective experiences and perspectives regarding treatment modalities. Q methodology is a research method that combines qualitative and quantitative paradigms, requiring participants to rank statements expressing their thoughts on a specific topic according to their own perspectives.
Study design
- Observational model
- Cohort
- Time perspective
- Other
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The hospital where the study will be conducted has a total of 13 adult peritoneal dialysis patients and 70 adult hemodialysis patients who regularly receive dialysis treatment and attend follow-up appointments. The aim is to study the entire peritoneal dialysis patient population. For hemodialysis patients, a similar number of patients (n=13) to the peritoneal dialysis patients will be selected using a simple randomization method, and these patients will be included in the study.
Key inclusion criteria (7 listed)
- Being between 18-65 years of age,
- Being able to read and write,
- Not having vision or hearing problems,
- Voluntary participation in our study,
- Being conscious,
Key exclusion criteria (1 listed)
- Wishing to withdraw from the research.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Perception of dialysis treatment
Time frame: up to 6 months
Hemodialysis patients were asked to rank 24 Q items, developed based on literature review and clinical experience, on a scale from -3 (strongly disagree) to +3 (strongly agree) according to a normal distribution model.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jun 2026.
Related trials for Dialysis Patients
RecruitingPhase 3
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Secondary Hyperparathyroidism, Chronic Kidney Disease
Not yet recruitingPhase 1/2
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
End Stage Renal Disease, Fatigue
Not yet recruitingObservational study
Malnutrition and Sarcopenia in Adults With Chronic Kidney Disease in Tunisia
Malnutrition, Sarcopenia
Not yet recruiting
Effects of Horticultural Therapy on Acute Stress and Salivary Cortisol Levels in Hemodialysis Patients
End-Stage Renal Disease, Renal Dialysis
RecruitingPhase 4
Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease
Heart Failure With Reduced Ejection Fraction, End Stage Renal Disease on Dialysis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yavuz Uren, PhD principal investigator
Yuzuncu Yil University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dialysis Patients, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Perception of dialysis treatment (time frame: up to 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.